Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Clinical trial NCT04575935 · RECRUITING

Trial details

NCT number: NCT04575935
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Ovarian Carcinoma Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Tumor Fallopian Tube Serous Neoplasm Fallopian Tube Transitional Cell Carcinoma Ovarian Clear Cell Adenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Serous Adenocarcinoma Ovarian Transitional Cell Carcinoma Primary Peritoneal Clear Cell Adenocarcinoma Primary Peritoneal Endometrioid Adenocarcinoma Primary Peritoneal Serous Adenocarcinoma

Start date: 2020-08-05
Primary completion: 2028-12-31
Enrollment: 580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.